Subscribe to Updates for A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Stay informed about the latest developments in this trial. By subscribing, you will receive updates directly to your email. These updates will provide you with important information regarding any changes or progress related to the trial.